Clinical Trial Detail

NCT ID NCT01266083
Title Trial of a WT-1 Analog Peptide Vaccine in Patients With Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

WT1 vaccine

Age Groups: adult

Additional content available in CKB BOOST